Is this you? Create Your Porfile
Avatar

Englert Heinrich Christian

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Englert Heinrich Christian is active.

Explore More

Publication

Featured researches published by Englert Heinrich Christian.

Archive | 2000

New 2,5-disubstituted benzenesulfonyl-ureas or -thioureas, used as ATP-sensitive potassium channel blockers for treating cardiovascular disorders such as arrhythmia or cardiac insufficiency

Heitsch Holger; Englert Heinrich Christian; Goegelein Heinz

Archive | 2002

Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

Heitsch Holger; Englert Heinrich Christian

Archive | 2001

Use of benzenesulfonyl(thio) ureas for treating and prophylaxis of autonomous nervous system dysfunctions and use of the benzenesulfonyl(thio) ureas in combination with beta-receptor blockers

Wirth Klaus; Englert Heinrich Christian; Bohn Helmut; Goegelein Heinz; Heitsch Holger; Gerlach Uwe

Archive | 2000

New cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, are ATP-sensitive potassium channel inhibitors and vagal nervous system stimulants useful for treating cardiovascular disorders

Heitsch Holger; Englert Heinrich Christian; Wirth Klaus; Goegelein Heinz

Archive | 2000

Kristalline form 3 des natriumsalzes von 5-chlor-2-methoxy-n-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonylphenyl)ethyl)benzamid

Englert Heinrich Christian; Gerlach Uwe; Metzenthin Tobias; Schneider Harald

Archive | 1998

3-AMIDOCHROMANYLSULFONYL (THIO)UREA, ITS PRODUCTION, USE THEREOF AND PHARMACEUTICAL PREPARATION COMPRISING THE SAME

Englert Heinrich Christian; Gerlach Uwe; Mania Dieter; Linz Wolfgang; Goegelein Heinz; Klaus Erik

Archive | 2011

derivados de benzenossulfonamida substituìda com cinamoilaminoalquila, processo para a sua preparação e respectiva composição farmacêutica.

Heitsch Holger; Englert Heinrich Christian; Wirth Klaus; Goegelein Heinz

Archive | 2011

Crystal modification 3 of sodium salt of 5-chloro-2-methoxy-N-[2-(4-methoxy-3-methyl-aminothiocarbonylaminosulfonylphenyl)ethyl]benzamide, process for its preparation, the modification for the use as medicament, pharmaceutical composition in which th

Englert Heinrich Christian; Gerlach Uwe; Metzenthin Tobias; Schneider Harald

Archive | 2010

SUBSTITUIERTE PYRROLIDIN-2-ONE, PIPERIDIN-2-ONE UND ISOTHIAZOLIDIN-1,1-DIOXIDE, IHRE VERWENDUNG ALS KV1.5 KALIUMKANALBLOCKER UND PHARMAZEUTISCHE ZUBEREITUNGEN, DIE SIE ENTHALTEN

Brendel Joachim; Englert Heinrich Christian; Peukert Stefan; Wirth Klaus; Wagner Michael; Ruxer Jean-Marie; Pilorge Fabienne

Archive | 2009

Substituerede heterocykliske forbindelser, deres anvendelse som medikament og farmaceutiske præparater, der omfatter disse

Wirth Klaus; Englert Heinrich Christian; Brendel Joachim; Pilorge Fabienne; Wagner Michael; Ruxer Jean-Marie

Explore More

Collaboration

Dive into the Englert Heinrich Christian's collaboration.

Top Co-Authors
Avatar

Gerlach Uwe

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Goegelein Heinz

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Heitsch Holger

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Brendel Joachim

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Linz Wolfgang

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Wirth Klaus

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Lang Hans Jochen

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Bohn Helmut

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Kleemann Heinz-Werner

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Weichert Andreas

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge